125 related articles for article (PubMed ID: 30419550)
21. 3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?
Tang K; Schuh AC; Yee KW
Curr Oncol Rep; 2021 Aug; 23(10):120. PubMed ID: 34350512
[TBL] [Abstract][Full Text] [Related]
22. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
Parovichnikova EN; Loukianova IA; Troitskaya VV; Drokov MY; Lobaova TI; Kuzmina LA; Sokolov AN; Kokhno AV; Fidarova ZT; Baskhaeva GA; Gavrilina OA; Vasilyeva VA; Obukhova TN; Kuznetsova SA; Sudarikov AB; Dvirnik VN; Galtseva IV; Davidiva JO; Kulikov SM; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):14-22. PubMed ID: 30701918
[TBL] [Abstract][Full Text] [Related]
23. Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Paubelle E; Ducastelle-Leprêtre S; Labussière-Wallet H; Nicolini FE; Barraco F; Plesa A; Salles G; Wattel E; Thomas X
Ann Hematol; 2017 Mar; 96(3):363-371. PubMed ID: 28011984
[TBL] [Abstract][Full Text] [Related]
24. Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.
Pluta A; Robak T; Wrzesien-Kus A; Katarzyna Budziszewska B; Sulek K; Wawrzyniak E; Czemerska M; Zwolinska M; Golos A; Holowiecka-Goral A; Kyrcz-Krzemien S; Piszcz J; Kloczko J; Mordak-Domagala M; Lange A; Razny M; Madry K; Wiktor-Jedrzejczak W; Grosicki S; Butrym A; Kuliczkowski K; Warzocha K; Holowiecki J; Giebel S; Szydlo R; Wierzbowska A
Am J Hematol; 2017 Apr; 92(4):359-366. PubMed ID: 28103640
[TBL] [Abstract][Full Text] [Related]
25. Lomustine in older patients with acute myeloid leukaemia.
Gourd E
Lancet Oncol; 2018 Nov; 19(11):e584. PubMed ID: 30293791
[No Abstract] [Full Text] [Related]
26. Cure of acute myelocytic leukemia in adults: a reality.
Geller RB; Saral R; Karp JE; Santos GW; Burke PJ
Leukemia; 1990 May; 4(5):313-5. PubMed ID: 2201825
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
Longu F; Fozza C; Dessì L; Longinotti M; Bonfigli S; Careddu MG; Coppola L; Giannico DB; Nieddu RM; Podda L; Pardini S; Dore F; Dore S; Sotgiu G
Acta Haematol; 2017; 137(1):15-16. PubMed ID: 27806360
[No Abstract] [Full Text] [Related]
28. New induction and postinduction strategies in acute myeloid leukemia.
Burnett AK
Curr Opin Hematol; 2012 Mar; 19(2):76-81. PubMed ID: 22248879
[TBL] [Abstract][Full Text] [Related]
29. Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).
Cassileth PA; Lee SJ; Litzow MR; Miller KB; Stadtmauer EA; Tallman MS; Lazarus HM; Bennett JM; Paietta E; Dewald GW; Rowe JM;
Leuk Lymphoma; 2005 Jan; 46(1):55-61. PubMed ID: 15621781
[TBL] [Abstract][Full Text] [Related]
30. Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax.
Diao S; Nichols ED; DiNardo C; Konopleva M; Ning J; Qiao W; Maiti A; DiPippo AJ
Am J Hematol; 2021 Mar; 96(3):E65-E68. PubMed ID: 33259075
[No Abstract] [Full Text] [Related]
31. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
[TBL] [Abstract][Full Text] [Related]
32. Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine.
Wiedower E; Jamy O; Martin MG
Anticancer Res; 2015 Nov; 35(11):6287-90. PubMed ID: 26504064
[TBL] [Abstract][Full Text] [Related]
33. Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.
Murphy T; Yee KWL
Expert Opin Pharmacother; 2017 Nov; 18(16):1765-1780. PubMed ID: 29017371
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.
Yoon JH; Cho BS; Kim HJ; Kim JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Am J Hematol; 2013 Dec; 88(12):1074-81. PubMed ID: 23983148
[TBL] [Abstract][Full Text] [Related]
35. [AML-7 study of the value of intensive remission induction in aged patients with acute myelocytic leukemia].
Jehn U; Löwenberg B
Onkologie; 1985 Apr; 8(2):97-8. PubMed ID: 3889758
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.
Doubek M; Palasek I; Brychtova Y; Buchtova I; Mayer J
Neoplasma; 2005; 52(5):411-4. PubMed ID: 16151586
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
[No Abstract] [Full Text] [Related]
38. Going beyond 7 + 3 regimens in the treatment of adult acute myeloid leukemia.
Tefferi A; Letendre L
J Clin Oncol; 2012 Jul; 30(20):2425-8. PubMed ID: 22529263
[No Abstract] [Full Text] [Related]
39. Outpatient administration of liposomal daunorubicin and cytarabine (Vyxeos) in patients with secondary acute myeloid leukemia.
Kasner MT
Clin Adv Hematol Oncol; 2019 Nov; 17(11):604-606. PubMed ID: 31851160
[No Abstract] [Full Text] [Related]
40. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
J Clin Oncol; 1990 Jul; 8(7):1199-206. PubMed ID: 1694236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
